ALEMBIC PHARMACEUTICALS
Back to Cashflow Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-164 Cr | ₹444 Cr | ₹-438 Cr | ₹-262 Cr | ₹-217 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-164 Cr |
| Mar2025 | ₹444 Cr |
| Mar2024 | ₹-438 Cr |
| Mar2023 | ₹-262 Cr |
| Mar2022 | ₹-217 Cr |
How is Cash Flow from Financing Activities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-164 Cr | Negative | |
| Mar2025 | ₹444 Cr | Positive | |
| Mar2024 | ₹-438 Cr | Negative | |
| Mar2023 | ₹-262 Cr | Negative | |
| Mar2022 | ₹-217 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,881.3 Cr | 0.3% | 2% | -9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 0.3% |
2% |
-9.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses